Masahiko Fushimi

Dotinurad versus benzbromarone in Japanese hyperuricemic patient with or without gout: a randomized, double-blind, parallel-group, phase 3 study

Tatsuo Hosoya, Takafumi Sano, Tomomitsu Sasaki et al. · Clinical and Experimental Nephrology · 2020 · 54 citations · Full text

Open-label study of long-term administration of dotinurad in Japanese hyperuricemic patients with or without gout

Tatsuo Hosoya, Masahiko Fushimi, Daisuke Okui et al. · Clinical and Experimental Nephrology · 2019 · 42 citations · Full text

Clinical efficacy and safety of dotinurad, a novel selective urate reabsorption inhibitor, in Japanese hyperuricemic patients with or without gout: randomized, multicenter, double-blind, placebo-controlled, parallel-group, confirmatory phase 2 study

Tatsuo Hosoya, Takafumi Sano, Tomomitsu Sasaki et al. · Clinical and Experimental Nephrology · 2019 · 26 citations · Full text

Ideal pharmacokinetic profile of dotinurad as a selective urate reabsorption inhibitor

Koichi Omura, Kengo Miyata, Seiichi Kobashi et al. · Drug Metabolism and Pharmacokinetics · 2020 · 19 citations · Full text

Clinical efficacy and safety of dotinurad, a novel selective urate reabsorption inhibitor, in Japanese hyperuricemic patients with or without gout: an exploratory, randomized, multicenter, double-blind, placebo-controlled, parallel-group early phase 2 study

Tatsuo Hosoya, Takafumi Sano, Tomomitsu Sasaki et al. · Clinical and Experimental Nephrology · 2019 · 18 citations · Full text